2型糖尿病患者使用抗炎药物后新发心力衰竭风险
基于丹麦全国登记数据,纳入1998至2021年诊断的331189例2型糖尿病患者,采用28天暴露窗的病例交叉设计,发现短期使用非甾体抗炎药(NSAIDs)与首次心力衰竭住院风险升高相关(OR 1.43;95%CI 1.27-1.63)。高龄、HbA1c升高且降糖药使用少、及新使用NSAIDs者风险更高。
要点
- 2型糖尿病患者短期使用NSAIDs与心衰住院风险增加相关(OR 1.43)。
- 年龄≥80岁、HbA1c升高且降糖药≤1种、新使用NSAIDs者风险更高。
- 处方NSAIDs时应评估心衰风险,尤其对高龄及新用药患者。
核心结论
- 在2型糖尿病患者中,NSAIDs使用广泛,且与首次心衰住院风险升高相关。
研究设计与样本
- 基于丹麦全国登记数据的病例交叉研究,纳入1998至2021年诊断的2型糖尿病患者,排除既往心衰、风湿病或诊断前120天内使用NSAIDs者,采用28天暴露窗。
主要发现
- 共纳入331189例2型糖尿病患者,女性44.2%,中位年龄62岁(IQR 52-71岁),随访期间23308例因心衰住院,16%患者在1年内至少一次NSAIDs处方。
- 短期使用NSAIDs与心衰住院风险升高相关(OR 1.43;95%CI 1.27-1.63)。
- 年龄≥80岁亚组OR 1.78(95%CI 1.39-2.28);HbA1c升高且使用0至1种降糖药亚组OR 1.68(95%CI 1.00-2.88);无既往NSAIDs使用亚组OR 2.71(95%CI 1.78-4.23)。
临床怎么用
- 对2型糖尿病患者处方NSAIDs时,应评估心衰风险,尤其关注高龄、HbA1c升高及新使用NSAIDs的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fluid retention and endothelial dysfunction have been related to use of nonsteroidal anti-inflammatory drugs (NSAIDs), and type 2 diabetes mellitus (T2DM) has been linked to both a decline in kidney function and subclinical cardiomyopathy. OBJECTIVES: The authors hypothesized that short-term use of NSAIDs could lead to subsequent development of incident heart failure (HF) in patients with T2DM. METHODS: Using nationwide Danish registers, we identified patients diagnosed with T2DM during 1998 to 2021 and included patients without previous HF, rheumatic disease, or use of NSAIDs 120 days before diagnosis. Associations between NSAIDs and first-time HF hospitalization were investigated using a case-crossover design with 28-day exposure windows, and ORs with 95% CIs were reported. RESULTS: Included were 331,189 patients with T2DM: 44.2% female, median age of 62 years (IQR: 52-71 years); 23,308 patients were hospitalized with HF during follow-up, and 16% of patients claimed at least 1 NSAID prescription within 1 year. Short-term use of NSAIDs was associated with increased risk of HF hospitalization (OR: 1.43; 95% CI: 1.27-1.63), most notably in subgroups with age ≥80 years (OR: 1.78; 95% CI: 1.39-2.28), elevated hemoglobin (Hb) A1c levels treated with 0 to 1 antidiabetic drug (OR: 1.68; 95% CI: 1.00-2.88), and without previous use of NSAIDs (OR: 2.71; 95% CI: 1.78-4.23). CONCLUSIONS: NSAIDs were widely used and were associated with an increased risk of first-time HF hospitalization in patients with T2DM. Patients with advanced age, elevated HbA1c levels, and new users of NSAID seemed more susceptible. These findings could guide physicians prescribing NSAIDs.
引用
- Holt, Strange, Nouhravesh, et al. Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2023. PMID: 37045515. doi:10.1016/j.jacc.2023.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。